Non-Hodgkin's Lymphoma Clinical Trials in Beijing
5 recruitingBeijing, China
Showing 1–5 of 5 trials
Recruiting
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Non-Hodgkin's LymphomaMycosis Fungoides
Stanford University2,000 enrolled13 locationsNCT02848274
Recruiting
Phase 1Phase 2
Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital30 enrolled2 locationsNCT05554939
Recruiting
Phase 1Phase 2
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital30 enrolled3 locationsNCT06014073
Recruiting
Phase 1Phase 2
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
Non-Hodgkin's Lymphoma
Beijing Mabworks Biotech Co., Ltd.132 enrolled1 locationNCT05806099
Recruiting
Phase 1Phase 2
Chidamide Bridging for CAR-T Therapy
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital120 enrolled13 locationsNCT05370547